vs
Cibus, Inc.（CBUS）与Galecto, Inc.（GLTO）财务数据对比。点击上方公司名可切换其他公司
Cibus, Inc.的季度营收约是Galecto, Inc.的1.1倍（$1.1M vs $1.0M），Cibus, Inc.净利率更高（-2959.9% vs -20053.5%，领先17093.7%），Galecto, Inc.同比增速更快（339.0% vs -12.8%），过去两年Galecto, Inc.的营收复合增速更高（50.5% vs 39.3%）
Cibus Inc.是一家领先的农业生物技术企业，专注于利用精准基因编辑技术开发可持续的优质作物性状，涵盖抗除草剂、抗病抗虫、产量提升等解决方案，服务全球农业市场、种子生产商及种植群体，助力降低农业生产环境负担，提高生产效率。
Galecto是一家生物科技公司，专注研发针对重症治疗的小分子药物，覆盖纤维化、癌症与炎症等治疗领域。公司由来自瑞典、英国、丹麦的半乳糖凝集素研究权威与生物科技行业高管于2011年创立，目前注册地位于美国，运营总部设在丹麦哥本哈根。
CBUS vs GLTO — 直观对比
营收规模更大
CBUS
是对方的1.1倍
$1.0M
营收增速更快
GLTO
高出351.8%
-12.8%
净利率更高
CBUS
高出17093.7%
-20053.5%
两年增速更快
GLTO
近两年复合增速
39.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $1.0M |
| 净利润 | $-31.3M | $-200.7M |
| 毛利率 | — | — |
| 营业利润率 | -2135.7% | -20149.5% |
| 净利率 | -2959.9% | -20053.5% |
| 营收同比 | -12.8% | 339.0% |
| 净利润同比 | -35.4% | -2877.8% |
| 每股收益（稀释后） | $-0.39 | $10.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBUSGLTO
| Q4 25 | $1.1M | $1.0M | ||
| Q3 25 | $615.0K | — | ||
| Q2 25 | $933.0K | — | ||
| Q1 25 | $1.0M | — | ||
| Q4 24 | $1.2M | $228.0K | ||
| Q3 24 | $1.7M | $146.0K | ||
| Q2 24 | $838.0K | $213.0K | ||
| Q1 24 | $545.0K | $257.0K |
净利润CBUSGLTO
| Q4 25 | $-31.3M | $-200.7M | ||
| Q3 25 | $-23.5M | — | ||
| Q2 25 | $-25.4M | — | ||
| Q1 25 | $-46.9M | — | ||
| Q4 24 | $-23.1M | $-6.7M | ||
| Q3 24 | $-180.0M | $-3.9M | ||
| Q2 24 | $-24.9M | $-5.3M | ||
| Q1 24 | $-23.4M | $-5.5M |
营业利润率CBUSGLTO
| Q4 25 | -2135.7% | -20149.5% | ||
| Q3 25 | -2510.2% | — | ||
| Q2 25 | -1923.5% | — | ||
| Q1 25 | -4020.4% | — | ||
| Q4 24 | -1487.1% | -3114.9% | ||
| Q3 24 | -12023.8% | -2630.1% | ||
| Q2 24 | -2563.5% | -2618.3% | ||
| Q1 24 | -3385.9% | -2233.9% |
净利率CBUSGLTO
| Q4 25 | -2959.9% | -20053.5% | ||
| Q3 25 | -3827.8% | — | ||
| Q2 25 | -2719.4% | — | ||
| Q1 25 | -4534.4% | — | ||
| Q4 24 | -1906.1% | -2956.6% | ||
| Q3 24 | -10795.9% | -2659.6% | ||
| Q2 24 | -2969.3% | -2506.1% | ||
| Q1 24 | -4300.0% | -2131.1% |
每股收益（稀释后）CBUSGLTO
| Q4 25 | $-0.39 | $10.86 | ||
| Q3 25 | $-0.44 | — | ||
| Q2 25 | $-0.61 | — | ||
| Q1 25 | $-1.34 | — | ||
| Q4 24 | $-0.94 | $-5.17 | ||
| Q3 24 | $-7.63 | $-3.39 | ||
| Q2 24 | $-1.14 | $-4.92 | ||
| Q1 24 | $-1.12 | $-5.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.9M | $257.6M |
| 总债务越低越好 | $528.0K | — |
| 股东权益账面价值 | $21.8M | $240.4M |
| 总资产 | $305.0M | $260.5M |
| 负债/权益比越低杠杆越低 | 0.02× | — |
8季度趋势，按日历期对齐
现金及短期投资CBUSGLTO
| Q4 25 | $9.9M | $257.6M | ||
| Q3 25 | $23.9M | — | ||
| Q2 25 | $36.5M | — | ||
| Q1 25 | $23.6M | — | ||
| Q4 24 | $14.4M | $14.2M | ||
| Q3 24 | $28.8M | $19.7M | ||
| Q2 24 | $30.0M | — | ||
| Q1 24 | $24.5M | $27.2M |
总债务CBUSGLTO
| Q4 25 | $528.0K | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $662.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CBUSGLTO
| Q4 25 | $21.8M | $240.4M | ||
| Q3 25 | $50.4M | — | ||
| Q2 25 | $72.1M | — | ||
| Q1 25 | $70.3M | — | ||
| Q4 24 | $92.2M | $15.8M | ||
| Q3 24 | $108.1M | $20.9M | ||
| Q2 24 | $270.5M | $23.6M | ||
| Q1 24 | $278.2M | $28.2M |
总资产CBUSGLTO
| Q4 25 | $305.0M | $260.5M | ||
| Q3 25 | $330.2M | — | ||
| Q2 25 | $346.2M | — | ||
| Q1 25 | $335.0M | — | ||
| Q4 24 | $350.1M | $17.1M | ||
| Q3 24 | $367.9M | $23.4M | ||
| Q2 24 | $553.4M | — | ||
| Q1 24 | $533.0M | $32.5M |
负债/权益比CBUSGLTO
| Q4 25 | 0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-13.4M | $566.0K |
| 自由现金流经营现金流 - 资本支出 | $-13.5M | — |
| 自由现金流率自由现金流/营收 | -1277.8% | — |
| 资本支出强度资本支出/营收 | 8.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-51.2M | — |
8季度趋势，按日历期对齐
经营现金流CBUSGLTO
| Q4 25 | $-13.4M | $566.0K | ||
| Q3 25 | $-11.7M | — | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $-11.8M | — | ||
| Q4 24 | $-14.0M | $-4.9M | ||
| Q3 24 | $-13.5M | $-3.7M | ||
| Q2 24 | $-17.0M | $-4.1M | ||
| Q1 24 | $-13.5M | $-5.9M |
自由现金流CBUSGLTO
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-11.8M | — | ||
| Q2 25 | $-13.7M | — | ||
| Q1 25 | $-12.1M | — | ||
| Q4 24 | $-14.1M | — | ||
| Q3 24 | $-13.9M | — | ||
| Q2 24 | $-17.2M | — | ||
| Q1 24 | $-13.7M | — |
自由现金流率CBUSGLTO
| Q4 25 | -1277.8% | — | ||
| Q3 25 | -1926.5% | — | ||
| Q2 25 | -1468.1% | — | ||
| Q1 25 | -1172.0% | — | ||
| Q4 24 | -1159.3% | — | ||
| Q3 24 | -832.3% | — | ||
| Q2 24 | -2054.5% | — | ||
| Q1 24 | -2515.2% | — |
资本支出强度CBUSGLTO
| Q4 25 | 8.1% | — | ||
| Q3 25 | 17.6% | — | ||
| Q2 25 | 10.0% | — | ||
| Q1 25 | 28.1% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 21.3% | — | ||
| Q2 24 | 20.2% | — | ||
| Q1 24 | 41.8% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
